WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy

Houston Methodist researchers identify B cells as driver of immunotherapy resistance in liver cancer

Despite major advances in immunotherapy, most patients with hepatocellular carcinoma fail to respond to current immune checkpoint inhibitors.

May 15, 2026

Vol.52 No.19

By Dan G. Duda

Clinical Roundup

University of Cincinnati achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy

Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first-in-the-world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment.

May 08, 2026

Vol.52 No.18

Clinical Roundup

“Forever chemicals” may be linked to childhood leukemia, UC Irvine study finds

Early exposure to PFAS, a group of widely used compounds known as “forever chemicals,” was associated with a higher risk of acute lymphoblastic leukemia, the most common childhood cancer, according to researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health.

May 01, 2026

Vol.52 No.17

Funding Opportunities

SITC seeks applications for two fellowships

Applications are now being accepted for the Society for Immunotherapy of Cancer fellowship opportunities. This year, SITC is offering two fellowships totaling $150,000 in funding.

March 20, 2026

Vol.52 No.11

Guest Editorial

As more people are surviving cancer, we must continue funding bold science

The cancer research community has a reason to celebrate. For the first time, 70% of people are living at least five years beyond their cancer diagnosis. And, as importantly, cancer death rates have been dropping relentlessly—by more than a third since 1991.

Cell-free DNA offers early warning for bloodstream infections in children with leukemia, St. Jude-led study finds

A study led by researchers at St. Jude Children’s Research Hospital shows that microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before the infection is apparent.

March 06, 2026

Vol.52 No.09

WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy

YOU MAY BE INTERESTED IN

Houston Methodist researchers identify B cells as driver of immunotherapy resistance in liver cancer

University of Cincinnati achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy

“Forever chemicals” may be linked to childhood leukemia, UC Irvine study finds

SITC seeks applications for two fellowships

As more people are surviving cancer, we must continue funding bold science

Cell-free DNA offers early warning for bloodstream infections in children with leukemia, St. Jude-led study finds

Renew today!

Subscriber content

Never miss an issue!

Login